Cargando…

Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature

RATIONALE: Aromatase inhibitors (AIs) are a class of drugs widely used in the treatment of estrogen sensitive breast and ovarian cancer which convert testosterone to estradiol and androstenedione to estrogen. The AIs of third generation, including anastrazole, letrozole and exemestane, have actually...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tenti, Sara, Giordano, Nicola, Cutolo, Maurizio, Giannini, Fabio, Fioravanti, Antonella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455664/ https://www.ncbi.nlm.nih.gov/pubmed/30921233 http://dx.doi.org/10.1097/MD.0000000000015052

Ejemplares similares

Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects
por: Tenti, Sara, et al.
Publicado: (2020)

Fibromyalgia Syndrome and Spa Therapy: Myth or Reality?
por: Guidelli, Giacomo M., et al.
Publicado: (2012)

New Trends in Injection-Based Therapy for Thumb-Base Osteoarthritis: Where Are We and where Are We Going?
por: Tenti, Sara, et al.
Publicado: (2021)

Can hybrid hyaluronic acid represent a valid approach to treat rizoarthrosis? A retrospective comparative study
por: Tenti, Sara, et al.
Publicado: (2017)

Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?
por: Tomasello, Riccardo, et al.
Publicado: (2021)

Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings
por: Ferrari, Giorgia, et al.
Publicado: (2021)

Could Oxidative Stress Regulate the Expression of MicroRNA-146a and MicroRNA-34a in Human Osteoarthritic Chondrocyte Cultures?
por: Cheleschi, Sara, et al.
Publicado: (2017)

Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
por: Corallo, Claudio, et al.
Publicado: (2019)

MiR-214-3p, a novel possible therapeutic target for the pathogenesis of osteoarthritis
por: Fioravanti, Antonella, et al.
Publicado: (2021)

The Mosaic of “Seronegative” Antiphospholipid Syndrome
por: Conti, Fabrizio, et al.
Publicado: (2014)

MicroRNA Mediate Visfatin and Resistin Induction of Oxidative Stress in Human Osteoarthritic Synovial Fibroblasts Via NF-κB Pathway
por: Cheleschi, Sara, et al.
Publicado: (2019)

Editorial: Primary Antiphospholipid Syndrome
por: Serrano, Antonio, et al.
Publicado: (2020)

Primary antiphospholipid syndrome presenting as antiphospholipid syndrome nephropathy: a case report
por: Abeysekera, Rajitha Asanga, et al.
Publicado: (2015)

A Complex Relationship between Visfatin and Resistin and microRNA: An In Vitro Study on Human Chondrocyte Cultures
por: Cheleschi, Sara, et al.
Publicado: (2018)

Prescription-grade crystalline glucosamine sulfate as an add-on therapy to conventional treatments in erosive osteoarthritis of the hand: results from a 6-month observational retrospective study
por: Tenti, Sara, et al.
Publicado: (2022)

Management of arthralgias associated with aromatase inhibitor therapy
por: Thorne, C.
Publicado: (2007)

Eruptive keloids associated with aromatase inhibitor therapy
por: Meade, Cathy, et al.
Publicado: (2015)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes
por: Cheleschi, Sara, et al.
Publicado: (2019)

B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?
por: van den Hoogen, Lucas L., et al.
Publicado: (2022)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Review of the Literature on Ocular Complications Associated With Aromatase Inhibitor Use
por: Almafreji, Ibrahim, et al.
Publicado: (2021)

Does Aromatase Inhibitors Cause Sjogren’s Syndrome and Polyneuropathy?
por: Yasar Bilge, Nazife Sule, et al.
Publicado: (2014)

A Combination of Celecoxib and Glucosamine Sulfate Has Anti-Inflammatory and Chondroprotective Effects: Results from an In Vitro Study on Human Osteoarthritic Chondrocytes
por: Cheleschi, Sara, et al.
Publicado: (2021)

An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis
por: Tenti, Sara, et al.
Publicado: (2023)

Molecular response to aromatase inhibitor treatment in primary breast cancer
por: Mackay, Alan, et al.
Publicado: (2007)

Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
por: Capecchi, Marco, et al.
Publicado: (2022)

Mycoplasma penetrans bacteremia and primary antiphospholipid syndrome.
por: Yáñez, A, et al.
Publicado: (1999)

Primary adrenal insufficiency in case of antiphospholipid syndrome
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Primary Adrenal Failure due to Antiphospholipid Syndrome
por: Sahin, Murat, et al.
Publicado: (2015)

Primary antiphospholipid syndrome presenting with homonymous quadrantanopsia
por: Yang, Hee Kyung, et al.
Publicado: (2018)

Bone loss and the aromatase inhibitors
por: Lester, J, et al.
Publicado: (2005)

Aromatase inhibitors in male sex
por: Singh, Santosh Kumar
Publicado: (2013)

Aromatase inhibitors in the treatment of endometriosis
por: Słopień, Radosław, et al.
Publicado: (2016)

Molecular Docking of Aromatase Inhibitors
por: Suvannang, Naravut, et al.
Publicado: (2011)

Aromatase Inhibitors in Erectile Dysfunction
por: Singh, Santosh
Publicado: (2021)

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts
por: Levy, Roger A., et al.
Publicado: (2015)

Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy
por: Lee, Eunyoung Emily, et al.
Publicado: (2021)

Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome
por: Binder, Gerhard, et al.
Publicado: (2021)

Antiphospholipid syndrome: state of the art on clinical practice guidelines
por: Limper, Marteen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1uccb2aa1g4v0cpucohda2tvk1